1. Signaling Pathways
  2. Membrane Transporter/Ion Channel
  3. URAT1

URAT1 (尿酸盐转运蛋白1)

Urate transporter 1; SLC22A12

URAT1, a member of the OAT (organic anion transporter) family was first cloned from the human kidney, where it is localized to the apical (brush border) membrane of renal proximal tubular cells. URAT1 mediates the reabsorption of uric acid, thereby regulating blood uric acid concentrations. Impairment in URAT1 activity, either due to polymorphisms, or drug-drug interactions, can have toxicological consequences. In the kidney, URAT1 is distributed along the renal tubular cell membrane and involved in reabsorption and excretion of uric acid, organic acids, drugs and their metabolites. Uric acid is taken up by OAT1 and OAT3 from the blood and reabsorbed into renal tubular cells via URAT1, in exchange for dicarboxylic acid. URAT1, along with OAT4 mediates uptake of uric acid from the renal tubule into renal tubular cells in exchange for organic anions such as lactic acid and nicotinic acid. This exchange is electroneutral and can be trans-stimulated by Cl- gradients and gradients of lactate transported by the sodium-monocarboxylate transporter. In the salivary glands, URAT1 is distributed along the entire surface, including the ductal and acinar cells, suggesting a role in the transport of organic acids and uric acid in the whole salivary gland.

URAT1 相关产品 (30):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-161523
    XOR/URAT1-IN-1 Inhibitor
    XOR/URAT1-IN-1 (Compound II15) 是黄嘌呤氧化还原酶 (XOR) 和尿酸转运蛋白 1 (URAT1) 的双重抑制剂,IC50 分别为 6 nM 和 12.9 μM。XOR/URAT1-IN-1 可降低由 Potassium oxonate (HY-17511) 或 Hypoxanthine (HY-N0091) 诱发的急性高尿酸血症小鼠模型中的尿酸水平。
    XOR/URAT1-IN-1
  • HY-152033
    URAT1 inhibitor 4 Inhibitor
    URAT1 inhibitor 4 是一种 Lesinurad 的衍生物,是口服有效的 URAT1 抑制剂,IC50 为 7.56 μM。URAT1 inhibitor 4具有比 Lesinurad (HY-15258) 更高的体内降尿酸效力。
    URAT1 inhibitor 4
  • HY-153706
    URAT1 inhibitor 5 Inhibitor
    URAT1 inhibitor 5 (compound 16) 是一种有效的URAT1抑制剂。URAT1 inhibitor 5 (compound 16) 可用于高尿酸血症的研究。
    URAT1 inhibitor 5
  • HY-158056
    URAT1/GLUT9-IN-1 Inhibitor
    URAT1/GLUT9-IN-1 (compound 29) 能抑制尿酸转运蛋白1 (URAT1) (IC50=2.01 μM) 和葡萄糖转运蛋白9 (GLUT9) (IC50=18.21 μM)。 URAT1/GLUT9-IN-1 具有良好的药代动力学特性和口服生物利用度。 URAT1/GLUT9-IN-1 可用于痛风和高尿酸血症的研究。
    URAT1/GLUT9-IN-1
  • HY-153972
    URAT1&XO inhibitor 2 Inhibitor 98.69%
    URAT1&XO inhibitor 2 (Compound BDEO) 是黄嘌呤氧化酶 (xanthine oxidase) 和 URAT1 的双重抑制剂,对黄嘌呤氧化酶的 IC50 为3.3 μM。URAT1&XO inhibitor 2 阻断表达URAT1的HEK293细胞对尿酸的摄取,Ki 值为0.145 μM。URAT1&XO inhibitor 2 降低高尿酸血症小鼠的血清尿酸盐水平和尿酸排泄。URAT1&XO inhibitor 2 用于高尿酸血症研究。
    URAT1&XO inhibitor 2
  • HY-156624
    Lingdolinurad Inhibitor
    Lingdolinurad 是尿酸转运蛋白抑制剂,靶向 hURAT1。Lingdolinurad 可用于高尿酸血症的体外和体内研究。
    Lingdolinurad
  • HY-159581
    URAT1&XO inhibitor 3 Inhibitor
    URAT1&XO inhibitor 3 (compound 27) 是一种口服有效的抗痛风试剂,靶向 XO (IC50: 35 nM) 和 URAT1 (IC50: 31 nM)。URAT1&XO inhibitor 3 具有良好的药理学和药代动力学 (PK) 特征和体内安全性。
    URAT1&XO inhibitor 3
  • HY-111345A
    Epaminurad hydrochloride Inhibitor
    Epaminurad (UR-1102) hydrochloride 是一种口服有效的和选择性的 URAT1 (尿酸转运体 1) 抑制剂,其 Ki 为 0.057 μM。Epaminurad hydrochloride 也可以抑制 OAT1OAT3 (有机阴离子转运体)。Epaminurad hydrochloride 是一种促尿酸排泄剂。Epaminurad hydrochloride 可用于痛风和高尿酸血症的研究。
    Epaminurad hydrochloride
  • HY-160265
    URAT1 inhibitor 9 Inhibitor
    URAT1 inhibitor 9 (Compound 24) 是 URAT1 抑制剂,可以用于痛风或高尿酸血症的研究。
    URAT1 inhibitor 9
  • HY-157306
    HC-1310
    HC-1310 URAT1抑制剂 (Compound 83) 是一种有效的 URAT1 抑制剂,可用于高尿酸血症和痛风的研究。
    HC-1310